In silico analysis of the effect of mutation on epidermal growth factor receptor in non-small-cell lung carcinoma: from mutational analysis to drug designing

References

• Adjakly, M., Ngollo, M., Boiteux, J. P., Bignon, Y. J., Guy, L., & Bernard-Gallon, D. (2013). Genistein and daidzein: Different molecular effects on prostate cancer. Anticancer Research, 33, 39–44.
   PubMed Web of Science ®Google Scholar
• Baker, N. A., Sept, D., Joseph, S., Holst, M. J., & McCammon, J. A. (2001). Electrostatics of nanosystems: Application to microtubules and the ribosome. Proceedings of the National Academy of Sciences, 98, 10037–10041.10.1073/pnas.181342398
   PubMed Web of Science ®Google Scholar
• Balch, P. A. (2006). Prescription for nutritional healing. New York, NY: Penguin.
   Google Scholar
• Berendsen, H. J., Postma, J. P., van Gunsteren, W. F., & Hermans, J. (1981). Interaction models for water in relation to protein hydration. In B. Pullman (Ed.), Intermolecular forces (pp. 331–342). Netherlands: Springer.
   Google Scholar
• Bukhari, S., Mokhdomi, T. A., Chikan, N. A., Amin, A., Qazi, H., Wani, S. H., … Mir, M. S. (2015). Affinity proteomics led identification of vimentin as a potential biomarker in colon cancers: insights from serological screening and computational modelling. Molecular BioSystems, 11, 159–169.10.1039/C4MB00506F
   PubMed Web of Science ®Google Scholar
• Chikan, N. A., Bhavaniprasad, V., Anbarasu, K., Shabir, N., & Patel, T. N. (2013). From natural products to drugs for epimutation computer-aided drug design. Applied Biochemistry and Biotechnology, 170, 164–175.10.1007/s12010-013-0158-6
   PubMed Web of Science ®Google Scholar
• Chikan, N., Bukhari, S., Shabir, N., Amin, A., Shafi, S., Qadri, R., & Patel, T. (2014). Atomic insight into the altered O6-methylguanine-DNA Methyltransferase protein architecture in gastric cancer. PLoS One, 10, e0127741–e0127741.
   Google Scholar
• Chikan, N. A., & Vipperla, B. (2014). KAISO inhibition: An atomic insight. Journal of Biomolecular Structure and Dynamics, 33, 1794–1804.
   PubMed Web of Science ®Google Scholar
• Dacic, S., Flanagan, M., Cieply, K., Ramalingam, S., Luketich, J., Belani, C., & Yousem, S. A. (2006). Significance of EGFR protein expression and gene amplification in non–small cell lung carcinoma. American Journal of Clinical Pathology, 125, 860–865.10.1309/H5UW6CPCWWC92241
   PubMed Web of Science ®Google Scholar
• DeLano, W. L. (2002). The PyMOL molecular graphics system.
   Google Scholar
• Essmann, U., Perera, L., Berkowitz, M. L., Darden, T., Lee, H., & Pedersen, L. G. (1995). A smooth particle mesh Ewald method. The Journal of Chemical Physics, 103, 8577–8593.10.1063/1.470117
   Web of Science ®Google Scholar
• Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., … Bray, F. (2015). Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer, 136, E359–E386.10.1002/ijc.29210
   PubMed Web of Science ®Google Scholar
• Hess, B., Bekker, H., Berendsen, H. J., & Fraaije, J. G. (1997). LINCS: A linear constraint solver for molecular simulations. Journal of Computational Chemistry, 18, 1463–1472.10.1002/(ISSN)1096-987X
   Web of Science ®Google Scholar
• Hess, B., Kutzner, C., van der Spoel, D., & Lindahl, E. (2008). GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. Journal of Chemical Theory and Computation, 4, 435–447.10.1021/ct700301q
   PubMed Web of Science ®Google Scholar
• Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14, 33–38.10.1016/0263-7855(96)00018-5
   PubMed Web of Science ®Google Scholar
• Jin, S., Zhang, Q. Y., Kang, X. M., Wang, J. X., & Zhao, W. H. (2010). Daidzein induces MCF-7 breast cancer cell apoptosis via the mitochondrial pathway. Annals of Oncology, 21, 263–268. doi:10.1093/annonc/mdp499
   PubMed Web of Science ®Google Scholar
• Johnson, B. E., & Jänne, P. A. (2005). Epidermal growth factor receptor mutations in patients with non–small cell lung cancer. Cancer Research, 65, 7525–7529.
   PubMed Web of Science ®Google Scholar
• Kobayashi, S., Boggon, T. J., Dayaram, T., Jänne, P. A., Kocher, O., Meyerson, M., … Halmos, B. (2005). EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. New England Journal of Medicine, 352, 786–792.
   PubMed Web of Science ®Google Scholar
• Kris, M. G., Natale, R. B., Herbst, R. S., Lynch, T. J., Jr., Prager, D., Belani, C. P., … Sandler, A. (2003). Efficacy of Gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non–small cell lung cancer. JAMA, 290, 2149–2158.10.1001/jama.290.16.2149
   PubMed Web of Science ®Google Scholar
• Kumari, R., Kumar, R., & Lynn, A. (2014). g_mmpbsa —A GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54, 1951–1962.10.1021/ci500020m
   PubMed Web of Science ®Google Scholar
• Kwak, E. L., Sordella, R., Bell, D. W., Godin-Heymann, N., Okimoto, R. A., Brannigan, B. W., … Lynch, T. J. (2005). Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib. Proceedings of the National Academy of Sciences, 102, 7665–7670.10.1073/pnas.0502860102
   PubMed Web of Science ®Google Scholar
• Lamartiniere, C. A., Wang, J., Smith-Johnson, M., & Eltoum, I. E. (2002). Daidzein: Bioavailability, potential for reproductive toxicity, and breast cancer chemoprevention in female rats. Toxicological Sciences, 65, 228–238.10.1093/toxsci/65.2.228
   PubMed Web of Science ®Google Scholar
• Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2012). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 64, 4–17.10.1016/j.addr.2012.09.019
   Web of Science ®Google Scholar
• Longo, D., Fauci, A., Kasper, D., & Hauser, S. (2011). Harrison’s Principles of Internal Medicine 18th edition. New York, NY: McGraw-Hill Professional.
   Google Scholar
• Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., … Haluska, F. G. (2004). Activating mutations in the epidermal growth factor receptor underlying responsiveness of non–small-cell lung cancer to gefitinib. New England Journal of Medicine, 350, 2129–2139.10.1056/NEJMoa040938
   PubMed Web of Science ®Google Scholar
• Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., … Boggon, T. J. (2004). EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy. Science, 304, 1497–1500.10.1126/science.1099314
   PubMed Web of Science ®Google Scholar
• Pao, W., Miller, V. A., Politi, K. A., Ricly, G., Somwar, R., Zakowski, M. F., … Varmus, H. (2005). Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. PLoS medicine, 2, e73.
   PubMed Web of Science ®Google Scholar
• Prewett, M., Rockwell, P., Rockwell, R., Giorgio, N. A., Mendelsohn, J., Scher, H. I., & Goldstein, N. I. (1996). The biologic effects of C225, a chimeric monoclonal antibody to the EGFR, on human prostate carcinoma. Journal of Immunotherapy, 19s, 419–427.10.1097/00002371-199611000-00006
   PubMed Web of Science ®Google Scholar
• Salvatori, L., Caporuscio, F., Coroniti, G., Starace, G., Frati, L., Russo, M. A., & Petrangeli, E. (2009). Down-regulation of epidermal growth factor receptor induced by estrogens and phytoestrogens promotes the differentiation of U2OS human osteosarcoma cells. Journal of Cellular Physiology, 220, 35–44. doi:10.1002/jcp.21724.
   PubMed Web of Science ®Google Scholar
• Shigematsu, H., & Gazdar, A. F. (2006). Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers. International Journal of Cancer, 118, 257–262.10.1002/(ISSN)1097-0215
   PubMed Web of Science ®Google Scholar
• Studio, D. (2012). version 3.5. San Diego, CA: Accelrys Inc.
   Google Scholar
• Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31, 455–461.
   PubMed Web of Science ®Google Scholar
• Turner, P. (2005). XMGRACE, Version 5.1. 19. Beaverton, OR: Center for Coastal and Land-Margin Research, Oregon Graduate Institute of Science and Technology.
   Google Scholar
• Viewer, S.-P. (2001). Kaplan W; Littlejohn TG. Briefings in bioinformatics, 2, 195–197.
   PubMedGoogle Scholar
• Williams, T., & Kelley, C. (1998). GNUplot: An interactive plotting program.
   Google Scholar
• Wrann, M., & Fox, C. (1979). Identification of epidermal growth factor receptors in a hyperproducing human epidermoid carcinoma cell line. Journal of Biological Chemistry, 254, 8083–8086.
   PubMed Web of Science ®Google Scholar
• Yun, C. H., Mengwasser, K. E., Toms, A. V., Woo, M. S., Greulich, H., Wong, K. K., … Eck, M. J. (2008). The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP. Proceedings of the National Academy of Sciences, 105, 2070–2075. doi:10.1073/pnas.0709662105
   PubMed Web of Science ®Google Scholar